Astec LifeSciences Limited (ASTEC.BO)
INR 1080.05
(-0.64%)
INR 1080.05
(-0.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -127.48 Million | 746.56 Million | 236.04 Million | -81.62 Million | 1.68 Billion | 152.85 Million |
| Net Income | -469.29 Million | 349.47 Million | 1.21 Billion | 890.7 Million | 613.52 Million | 559.04 Million |
| Depreciation & Amortization | 362.53 Million | 336.52 Million | 343.56 Million | 256.55 Million | 231.64 Million | 193.49 Million |
| Deferred income taxes | - | -50.33 Million | -283.88 Million | -235.45 Million | -162.86 Million | -176.01 Million |
| Stock-based compensation | 3.01 Million | 3.3 Million | 1.04 Million | 99 Thousand | 555 Thousand | 1.63 Million |
| Change in working capital | 104.93 Million | -59.06 Million | -1.12 Billion | -1.03 Billion | 878.26 Million | -545.43 Million |
| Other non-cash items | 633.66 Million | 166.65 Million | 87.94 Million | 39.66 Million | 123.28 Million | 120.13 Million |
| Investing Cash Flow | -1.35 Billion | -1.12 Billion | -1.03 Billion | -731.09 Million | -738.1 Million | -524.99 Million |
| Investments in PPE | -1.35 Billion | -1.17 Billion | -1.03 Billion | -1.02 Billion | -452.94 Million | -527.75 Million |
| Acquisitions | 3.59 Million | 7.76 Million | 1.23 Million | 48 Thousand | 1.57 Million | 161 Thousand |
| Investment purchases | -2.76 Million | -1.1 Million | - | -324 Thousand | 811 Thousand | -1.02 Million |
| Sales/Maturities of investments | - | - | - | 5.8 Million | 1.09 Million | 3.62 Million |
| Other Investing Activities | 3.16 Million | 39.75 Million | -115 Thousand | 288.65 Million | -288.65 Million | -1000.00 |
| Financing Cash Flow | 1.48 Billion | 377.7 Million | 804.77 Million | 813.36 Million | -945.34 Million | 370.94 Million |
| Debt repayment | -1.01 Billion | -427 Million | -920.26 Million | -883.5 Million | -783.07 Million | -527.29 Million |
| Dividends payments | -29.4 Million | -29.4 Million | -29.37 Million | -29.35 Million | -35.36 Million | -35.34 Million |
| Common Stock Repurchased | - | - | 1.84 Billion | 1.76 Billion | -129.1 Million | -123.75 Million |
| Common Stock Issuance | 790 Thousand | 1.3 Million | 2.99 Million | 6.73 Million | 2.19 Million | 2.76 Million |
| Other Financing Activities | 500 Million | 832.8 Million | -89.1 Million | -47.51 Million | -6.03 Million | 1.05 Billion |
| Accounts receivables | -135.32 Million | 1.21 Billion | -837.69 Million | -310 Million | -343.57 Million | -15.57 Million |
| Accounts payables | -888.04 Million | -142.75 Million | 607.15 Million | -700.53 Million | 1.31 Billion | -355.49 Million |
| Inventory | 989.1 Million | -1.08 Billion | -831.41 Million | 150.79 Million | -283.21 Million | -143.71 Million |
| Other working capital | 139.19 Million | -45.59 Million | -61.93 Million | -173.44 Million | 193.52 Million | -30.65 Million |
| Cash at beginning of period | 5.2 Million | 5.54 Million | 3.38 Million | 3.08 Million | 2.12 Million | 3.31 Million |
| Cash at end of period | 24.32 Million | 4.73 Million | 5.54 Million | 3.38 Million | 3.08 Million | 2.12 Million |
| Capital Expenditure | -1.35 Billion | -1.17 Billion | -1.03 Billion | -1.02 Billion | -452.94 Million | -527.75 Million |
| Effect of forex changes on cash | - | - | - | -336 Thousand | 2000.00 | -1000.00 |
| Net cash flow / Change in cash | 19.12 Million | -811 Thousand | 2.15 Million | 307 Thousand | 958 Thousand | -1.18 Million |
| Free Cash Flow | -1.48 Billion | -426.03 Million | -803.74 Million | -1.1 Billion | 1.23 Billion | -374.89 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -397.24 Million | -9.73 Million | -469.29 Million | -243.34 Million | -134.27 Million | -81.94 Million |
| Depreciation & Amortization | - | - | 362.53 Million | 87.03 Million | 91.58 Million | 93.85 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 3.01 Million | 3.01 Million | - | - | - |
| Change in working capital | - | - | 104.93 Million | - | - | - |
| Other non-cash items | 397.24 Million | 6.72 Million | 633.66 Million | 243.34 Million | 134.27 Million | 81.94 Million |
| Investing Cash Flow | - | - | -1.35 Billion | - | - | - |
| Investments in PPE | - | - | -1.35 Billion | - | - | - |
| Acquisitions | - | - | 3.59 Million | - | - | - |
| Investment purchases | - | - | -2.76 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 3.16 Million | - | - | - |
| Financing Cash Flow | - | - | 1.48 Billion | - | - | - |
| Debt repayment | - | - | -1.01 Billion | - | - | - |
| Dividends payments | - | - | -29.4 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 790 Thousand | - | - | - |
| Other Financing Activities | - | - | 500 Million | - | - | - |
| Accounts receivables | - | - | -135.32 Million | - | - | - |
| Accounts payables | - | - | -888.04 Million | - | - | - |
| Inventory | - | - | 989.1 Million | - | - | - |
| Other working capital | - | - | 139.19 Million | - | - | - |
| Cash at beginning of period | - | - | 5.2 Million | 25.5 Million | 159.77 Million | 5.2 Million |
| Cash at end of period | - | - | 24.32 Million | -243.34 Million | 25.5 Million | -81.94 Million |
| Capital Expenditure | - | - | -1.35 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 19.12 Million | -268.84 Million | -134.27 Million | -87.15 Million |
| Free Cash Flow | - | - | -1.48 Billion | -243.34 Million | -134.27 Million | -81.94 Million |
SASKEN
PUUILO
300699
BETR
9594
WAY